NCT05633745View on ClinicalTrials.gov

A Study to Assess NEU-723 in Healthy Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Healthy
Interventions
DRUG

NEU-723

Oral Doses

DRUG

Placebo

Oral Doses

Trial Locations (1)

Unknown

New Zealand Clinical Research, Christchurch

Sponsors

Lead Sponsor

Neuron23 Inc.
All Listed Sponsors
lead

Neuron23 Inc.

INDUSTRY

NCT05633745 - A Study to Assess NEU-723 in Healthy Participants | Biotech Hunter | Biotech Hunter